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variety of organs and diseases. The intestinal organoids have 
been shown to be a very power tool for the study of Cancer, 
Cystic Fibrosis and Inflammatory Bowel Disease (Dekkers, Nat 
Med 2013; van de Wetering, Cell in press). The models 
represent previously unavailable in vitro models and patient 
specific samples for drug development, patient stratification 
and diagnostics. In addition, we recently showed the 
organoids are amendable to genetic corrections by novel and 
conventional biochemical techniques such as Crispr/Cas9 
(Drost et al., Nature 2015; Schwank et al., Cell Stem Cell 
2013). Finally, the in vitro stability of the organoid was 
demonstrated by the integration after transplantation of 
human liver cells into recipient mice. This makes the 
organoid a unique new platform for drug development, for 
precision medication for patients in the clinic, and a possible 
new source for cell therapy.  
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Following ionizing radiation exposure, double strand DNA 
breaks activate the ataxia telangiectasia mutated (ATM) 
kinase, which then phosphorylates a large number of target 
proteins to orchestrate the DNA damage response. One of the 
key proteins that is activated by ionizing radiation in an ATM-
dependent manner is the tumor suppressor protein p53. Our 
laboratory has utilized the Cre-loxP system to delete ATM, 
p53 or both genes in different cell types in mice. We have 
also employed reversible in vivo shRNA to temporarily inhibit 
p53 during radiation exposure. We find that the roles of ATM 
and p53 in normal tissue radiation response are cell type 
specific. In bone marrow exposed to radiation, p53 acts to 
kill stem and progenitor hematopoietic cells, which increases 
acute hematological toxicity and promotes radiation-induced 
lymphomas. In gastrointestinal epithelial cells, p53 prevents 
the radiation-induced gastrointestinal syndrome. In 
endothelial cells, p53 prevents radiation-induced heart 
disease. Although deletion of ATM in endothelial cells does 
not sensitize mice to radiation-induced cardiac injury, in the 
setting of p53 deletion, ATM further sensitizes mice to 
radiation-induced heart disease. Taken together, these 
studies define cell type specific roles for ATM and p53 in 
mediating normal tissue response to ionizing radiation and 
suggest opportunities for combining radiotherapy with 
inhibitors of the ATM-p53 pathway to improve the 
therapeutic ratio when treating cancers at specific anatomic 
sites. 
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Due to its anatomical localization and high turnover, 
epidermis is a major target for carcinogens, and skin 
carcinoma is one of the most frequent human cancers. 
Ionizing radiation (IR) can induce carcinoma in skin, but the 
respective roles of keratinocyte stem cells and their progeny 
in the carcinogenic process is unclear. We characterized cell 
intrinsic radiosensitivity of keratinocyte stem cells (KSC) to 
gamma rays. Primary KSC were found radioresistant to high 
radiation doses (Rachidi, 2007), as well as to low doses. They 
repair rapidly all types of DNA damage (Harfouche, 2010), 
both after ionizing radiation and UVB exposure (Marie, 
submitted), without going to apoptosis. Activated repair was 
notably due to increased levels of DNA repair proteins and 
activation of nuclear FGF2 signaling. To evaluate the 
potential impact of irradiation on the epigenetic status of 
keratinocyte precursor cells, the Illumina 450K array was 
used, which measures the methylation level of 480,000 
methylation sites (or CpG islands). More than 36 million of 
GpCs have been identified in the human genome, most of 
them located directly in gene sequences or in gene 
promoters. In the present study, analysis of the lists of the 
modified genes obtained by normalized graph-cut DNA-
ranking allowed the definition of: 1) a specific signature of 
long-term alterations after 2 Gy: hundred genes presented 
methylation changes over 3 weeks in culture, with 18 genes 
exhibiting the most discriminant methylation changes at 16 
and 23 days after exposure. Six genes were members of the 
super-family of protocadherins of the alpha type, pointing to 
alterations of cell-cell interactions. 2) a specific signature of 
long-term alterations after 10 mGy: 15 specific genes had 
methylation changes that were discriminant after 16 and 23 
days. From their functions, it appears that the major cell 
responses after 10 mGy were localized at the cell membrane, 
for processes involved in calcium-related cell adhesion, 
signaling, energy status and carcinoma development. As a 
major function of methylation changes is to inhibit 
transcription, these signatures have been validated by 
characterizing the expression of the genes found in the 
signatures. In summary, high and low-dose exposures of 
immature keratinocytes from human epidermis result in 
epigenetic changes, part of them being specific to the dose. 
Methylation changes appear to regulate notably cell functions 
related to cell-cell interactions, cell adhesion and energy 
status.  
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Background: One of the main aims of radiotherapy alone or 
combined with chemo-, immuno- or biologically targeted 
therapy is the maximisation of tumour tissue eradication 
whilst preserving the surrounding normal tissue. This requires 
a deep understanding of the molecular mechanisms of 
radiation sensitivity in order to identify its key players and 
potential therapeutic targets. Currently, a paradigm shift is 
taking place from pure frequentistic association analysis to 
the rather holistic systems biology approach that seeks to 
mathematically model the system to be investigated and to 
allow the prediction of an altered phenotype as the function 
of one single or a signature of biomarkers.  
 
Methods: In the current study cell culture models of 
radiation-resistant tumour cells and normal radiation-
sensitive cells were investigated by multi-level (genome, 
transcriptome, miRNA) omics profiling over time and the 
resulting multi-layer radiation interactome was 
reconstructed. Validation of key network elements in biopsy-
derived multi-omics data from radiotherapy treated HNSCC 
patients was performed and tested for association with 
clinical outcome.  
 
Results: Molecular frameworks including signalling pathways 
senescence, cell cycle, immune system and PI3K/Akt have 
been identified and are therefore likely to drive radiation 
response in tumour and normal cells. Moreover, the 
identified networks could be used to identify molecular key 
players and potential targets for the simultaneous modulation 
